The novel treatment of tirzepatide peptide represents a exciting advance in the care of diabetes mellitus type 2. Different to existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide002805.blogoxo.com/42473418/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment